Your window to advances in

life science and technologies

 in China and Japan

Klick at the button to get to the websites

We are a small team of scientists from Germany, China and Japan, located in Stuttgart, Germany, and fascinated by the advances of the life sciences and their “bio-digital” integration. Since more than ten years, we collect life science- and technology-related news from China, Japan and other Asian nations, day by day. We provide short summaries of these news on our websites www.window-to-china.de and www.window-to-japan.eu

Some of these news are discussed in more depth in books, reports or articles.  Recent examples are shown below. 

We also publish news from Japan and China through LinkedIn and Twitter (in English), XING and “Nachrichten aus der Chemie” (in German).

We also have done single-client studies and competitive analysis on life-science related issues and IP for various European companies. If you should be interested in such kind of a study, please contact rolf.d.schmid@bio4business.eu

 

30 – 60 pages reports for the EU-Japan Centre for Industrial Cooperation in Brussels/Tokyo in English. Copies can be obtained free of charge through https://www.eu-japan.eu after registration.

30 – 60 pages reports for the EU-Japan Centre for Industrial Cooperation in Brussels/Tokyo in English. Copies can be obtained free of charge through https://www.eu-japan.eu after registration.

Report in English (2017, 63 pages) on China’s strategies in Medical Biotechnology during the 13th Five-Years program. An update (in German) will be published by the end of 2021. The brochure can be downloaded for free from German Trade and Invest (GTAI) through https://www.exportinitiative-gesundheitswirtschaft.de/EIG/Redaktion/DE/Publikationen/PDF/medical-biotechnology-profiling-china.html

Report in English (2017, 63 pages) on China’s strategies in Medical Biotechnology during the 13th Five-Years program. An update (in German) will be published by the end of 2021. The brochure can be downloaded for free from German Trade and Invest (GTAI) through https://www.exportinitiative-gesundheitswirtschaft.de/EIG/Redaktion/DE/Publikationen/PDF/medical-biotechnology-profiling-china.html

Report in German (2019, 23 pages) on the Japanese market of drugs and biopharmaceuticals which includes regulatory issues, pricing, marketing, cultural aspects and main actors. The brochure can be downloaded from German Trade and Invest (GTAI) through The brochure can be downloaded for free from German Trade and Invest (GTAI) through https://www.exportinitiative-gesundheitswirtschaft.de/EIG/Redaktion/DE/Publikationen/PDF/gesundheitsmarkt-japan.html

Report in German (2019, 23 pages) on the Japanese market of drugs and biopharmaceuticals which includes regulatory issues, pricing, marketing, cultural aspects and main actors. The brochure can be downloaded from German Trade and Invest (GTAI) through The brochure can be downloaded for free from German Trade and Invest (GTAI) through https://www.exportinitiative-gesundheitswirtschaft.de/EIG/Redaktion/DE/Publikationen/PDF/gesundheitsmarkt-japan.html

Book in English, 350 pages, 2021, Jenny Stanford publisher, Singapore. Available as eBook ISBN-13 978-9814877534, soon as hardcover ISBN-10 9814877530

Book in English, 350 pages, 2021, Jenny Stanford publisher, Singapore.

Available as eBook ISBN-13 978-9814877534, and as hardcover ISBN-10 9814877530

Mini Review of Biotech in China 2021, by Schmid and Xiong published in Applied Microbiology and Biotechnology
Monthly newsletter in German, 8 – 10 pages per month, on pharmaceutical legislation, new regulations and market trends in China. Since July 2018. Annual index also available. Available, free of cost, through Germany Trade and Invest (GTAI), https://www.exportinitiative-gesundheitswirtschaft.de/EIG/Navigation/DE/Branchen/Arzneimittel/PharmaUpdateNeu/pharmaUpdate-neu.html

Monthly newsletter in German, 8 – 10 pages per month, on pharmaceutical legislation, new regulations and market trends in China. Since July 2018. Annual index also available.

Available, free of cost, through Germany Trade and Invest (GTAI), https://www.exportinitiative-gesundheitswirtschaft.de/EIG/Navigation/DE/Branchen/Arzneimittel/PharmaUpdateNeu/pharmaUpdate-neu.html

Monthly newsletter in German, 8 – 10 pages per month, on medtech-related legislation, new regulations and market trends in China. Since July 2018. Annual index also available. Available, free of cost, through Germany Trade and Invest (GTAI), https://www.exportinitiative-gesundheitswirtschaft.de/EIG/Navigation/DE/Branchen/Arzneimittel/PharmaUpdateNeu/pharmaUpdate-neu.html

Monthly newsletter in German, 8 – 10 pages per month, on medtech-related legislation, new regulations and market trends in China. Since July 2018. Annual index also available.

Available, free of cost, through Germany Trade and Invest (GTAI), https://www.exportinitiative-gesundheitswirtschaft.de/EIG/Navigation/DE/Branchen/Arzneimittel/PharmaUpdateNeu/pharmaUpdate-neu.html

Get in Touch

Bio4Business

Founder and CEO: Rolf D. Schmid

USt.-IdNr.: DE162899378

All rights reserved

Visit

Jagdweg 3 D-70569 Stuttgart, Germany